Skip to main content
< Back to news
INBRAIN Neuroelectronics graphene-based brain-computer interface semiconductor technology. Photo / INBRAIN Neuroelectronics
 06.05.2025

INBRAIN Neuroelectronics receives 4 M€ from the Spanish PERTE Chip programme for the development of brain-computer interfaces

The neurotechnology company INBRAIN Neuroelectronics, located in the Barcelona Science Park, has received a 4 million euro grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative, a national programme to support the most revolutionary innovation in microelectronics, semiconductors and deeptech. With this investment, the company is promoting the development of the graphene-based precision brain-computer interface (BCI) technology to modify and modulate brain activity in real time for the treatment of neural diseases.

The ICREA and ICN2 spinoff has developed the world’s first neural graphene interface for the treatment of central nervous system (CNS) diseases. This technology has already been successfully tested in cancer patients, and proofs of concept have also been published with promising results in applications for epilepsy, Parkinson’s disease and stroke. INBRAIN’s Brain-Computer Interface Therapeutics (BCI-Tx) platform is based on the exceptional properties of graphene, a Nobel Prize-winning material renowned for its strength, flexibility and high resolution in neural signal detection.

The PERTE Chip initiative (Strategic Project for the Recovery and Economic Transformation of Microelectronics and Semiconductors) aims to strengthen, from an integral perspective, the design and production capacities of the Spanish microelectronics and semiconductor industry, while promoting strategic technological autonomy, both for Spain.

INBRAIN Neuroelectronics has been one of the 37 projects selected from all over Spain for its transformative potential. “This grant will allow us to accelerate the mission of developing precision nanotechnologies capable of transforming the treatment of neurological diseases, while contributing to position Spain at the forefront of innovation in deep technology for health care,” explained Carolina Aguilar, CEO and co-founder of INBRAIN Neuroelectronics.

“INBRAIN Neuroelectronics represents exactly the type of cutting-edge innovation that we want to support at the Government of Catalonia”, said Miquel Sàmper, Minister of Enterprise and Employment of the Government of Catalonia. “By combining neurotechnology with advanced materials such as graphene, INBRAIN is not only pushing the boundaries of health innovation, but also reinforcing the leadership of Catalonia, Spain and Europe in strategic sectors of deep technology. Supporting projects like this is essential for building the country’s technological autonomy and long-term competitiveness”.